Guanine nucleotides protect against kainate toxicity in an ex vivo chick retinal preparation

FEBS Letters

Volumn 430, Issue 3, 1998, Pages 176-180

  Burgos, Javier S ^a   Barat, Ana ^a   Souza, Diogo O ^b   Ramírez, Galo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b U   (Brazil)

Author keywords

Chick retina; Excitotoxicity; Guanine nucleotide; Guanosine monophosphate; Kainate; Neuroprotection

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; GLUTAMATE RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE; KAINIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHICK EMBRYO; DRUG POTENCY; EMBRYO; MOLECULAR INTERACTION; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RETINA DEGENERATION;

ANIMALS; BINDING SITES; CELL MEMBRANE; CHICK EMBRYO; CULTURE TECHNIQUES; EXCITATORY AMINO ACID ANTAGONISTS; GUANINE NUCLEOTIDES; KAINIC ACID; QUINOXALINES; RETINA;

ANIMALIA;

EID: 0032479349     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00651-6     Document Type: Article

References (28)

1. Sharif N.A., Roberts P.J. Biochem. Pharmacol. 30:1981;3019-3022.
2. Monahan J.B., Hood W.F., Michel J., Compton R.P. Mol. Pharmacol. 34:1988;111-116.
3. Baron B.N., Dudley M.W., McCarty D.R., Miller F.P., Reynolds I.J., Schmidt C.J. J. Pharmacol. Exp. Ther. 250:1989;162-169.
4. Souza D.O., Ramírez G. J. Mol. Neurosci. 3:1991;39-45.
5. Gorodinsky A., Paas Y., Teichberg V.I. Neurochem. Int. 23:1993;285-291.
6. Barnes J.M., Murphy P.A., Kirkham D., Henley J.M. J. Neurochem. 61:1993;1685-1691.
7. Tasca C.I., Wofchuk S.T., Souza D.O., Ramírez G., Rodnight R. NeuroReport. 6:1995;249-252.
8. Tasca C.I., Cardoso L.F., Martini L.H., Ramírez G., Souza D.O. Neurochem. Res. 23:1998;183-188.
9. Paas Y., Devillers-Thiéry A., Changeux J.-P., Medevielle F., Teichberg V.I. EMBO J. 15:1996;1548-1556.
10. Ramos M., Souza D.O., Ramírez G. FEBS Lett. 406:1997;114-118.
11. Malcon C., Achaval M., Komlos F., Partata W., Sauressig M., Ramírez G., Souza D.O. Neurosci. Lett. 225:1997;145-148.
12. Regner A., Ramírez G., Belló-Klein A., Souza D. Neurochem. Res. 23:1998;523-528.
13. Lucas D.R., Newhouse J.P. Am. Med. Assoc. Arch. Ophthalmol. 58:1957;193-201.
14. Olney J.W. J. Neuropathol. Exp. Neurol. 28:1969;455-474.
15. Gibson B.L., Reif-Lehrer L. Dev. Brain Res. 15:1984;97-103.
16. Olney J.W., Price M.T., Samson L., Labruyere J. Neurosci. Lett. 65:1986;65-71.
17. De Nardis R., Sattayasai J., Zappia J., Ehrlich D. Dev. Neurosci. 10:1988;256-269.
18. Zeevalk G.D., Hyndman A.G., Nicklas W.J. J. Neurochem. 53:1989;1610-1619.
19. Romano C., Price M.T., Olney J.W. J. Neurochem. 65:1995;59-67.
20. Allcorn S., Catsicas M., Mobbs P. Eur. J. Neurosci. 8:1996;2499-2510.
21. Eggett C.J., O'Leary T.A., Reynolds G.P. Neurosci. Lett. 219:1996;65-67.
22. John, R.A. (1993) in: Enzyme Assays. A Practical Approach (Eisenthal, R. and Danson, M.J., Eds.), pp. 59-92, IRL Press, Oxford.
23. Biziere K., Coyle J.T. Neuropharmacology. 18:1979;409-413.
24. Olney, J.W. (1978) in: Kainic Acid as a Tool in Neurobiology (McGeer, E., Olney, J.W. and McGeer, P., Eds.), pp. 95-121, Raven Press, New York.
25. Gómez-Barriocanal J., Barat A., Ramírez G. Neurochem. Int. 4:1982;157-166.
26. Morgan I.G., Ingham C.A. Neurosci. Lett. 21:1981;275-280.
27. Catsicas S., Clarke P.G.H. J. Comp. Neurol. 262:1987;512-522.
28. Bennet M.V.L., Pellegrini-Gampietro D.E., Gorter J.A., Aronica E., Connor J.A., Zukin R.S. Cold Spring Harbor Symp. Quant. Biol. 61:1996;373-384.